UNII GR686LBA74

SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM

Unique Ingredient Identifier GR686LBA74 is listed as a unspecified ingredient
UniiGR686LBA74
Preferred Substance NameSODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM
Rn10140-65-5
NcitC66545
Rxcui236719
Unii TypeUNSPECIFIED INGREDIENT
RN10140-65-5
NCITC66545
RXCUI236719

Alternate Names

Dosage Forms

UNII GR686LBA74 SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM is commonly included in medications in the following forms.

RouteDosage FormPotency
ORALSUSPENSION8 mg/1mL
IM - IVINJECTABLE4 %
IM - IVINJECTION ADJPH
IM - IVPOWDER, FOR INJECTION SOLUTION4 %
INTRADERMALINJECTION0.2 %
INTRALESIONALSUSPENSION, INJECTION0.14 %
INTRAMUSCULARINJECTABLE4 %
INTRAMUSCULARINJECTION0.48 %W/V
INTRAMUSCULARPOWDER, FOR INJECTION SOLUTION1.75 %W/V
INTRAMUSCULARSUSPENSION, INJECTION0.14 %W/V
INTRASYNOVIALSUSPENSION, INJECTION0.14 %
INTRAVENOUSINJECTABLE200 MG/1VIAL
INTRAVENOUSINJECTABLE4 %
INTRAVENOUSINJECTION0.76 %
INTRAVENOUSPOWDER, FOR INJECTION SOLUTION1.75 %
INTRAVENOUSPOWDER, FOR INJECTION SOLUTION, LYOPHILIZED3.25 %
INTRAVENOUSSOLUTION, INJECTION1.88 MG/1ML
INTRAVENOUSSOLUTION, INJECTION0.11 %
IV(INFUSION)INJECTION NA
IV(INFUSION)POWDER, FOR INJECTION SOLUTION4 %
IV(INFUSION)POWDER, FOR INJECTION SOLUTION, LYOPHILIZED0.38 %
IV(INFUSION)SOLUTION0.013 %
NASALSOLUTION, SPRAY0.65 %
NASALSPRAY352.09 MCG/SPRAY
NASALSPRAY ADJPH
NASALSPRAY, METERED0.3 %
OPHTHALMICSOLUTION0.51 %
OPHTHALMICSUSPENSION0.43 %
ORALCONCENTRATE17 MG/5ML
ORALSOLUTION140 MG/5ML
ORALSOLUTION, LIQUID1.5 MG/1ML
ORALSUSPENSION4.5 MG/1ML
ORALSYRUP3.5 MG/1GM
ORALTABLET, EXTENDED RELEASE71.5 MG
ORALTABLET, UNCOATED, LOZENGE31 MG
SOFT TISSUESUSPENSION, INJECTION0.14 %
SUBCUTANEOUSINJECTION0.66 %
SUBCUTANEOUSPOWDER, FOR INJECTION SOLUTION, LYOPHILIZED0.3 %
SUBCUTANEOUSSUSPENSION, INJECTION0.09 %
TOPICALEMULSION, CREAM0.1 %W/W
TOPICALOINTMENT0.026 %W/W
TOPICALSOLUTION0.51 %W/V
TRANSMUCOSALTABLET, UNCOATED, LOZENGE28 MG

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.